Recurrent tumefactive demyelination under fingolimod treatment

Neurol Sci. 2024 May;45(5):2377-2378. doi: 10.1007/s10072-024-07310-4. Epub 2024 Jan 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Fingolimod Hydrochloride / adverse effects
  • Humans
  • Magnetic Resonance Imaging
  • Multiple Sclerosis* / drug therapy

Substances

  • Fingolimod Hydrochloride